If you’re leading risk adjustment for a health plan right now, you’re probably living in a constant tension.

Chart volume keeps climbing. Chase lists don’t get smaller. Leadership wants improved RAF performance without a proportional increase in headcount or vendor cost. Everyone wants throughput.

At the same time, CMS scrutiny is only getting tighter. RADV audits aren’t going away, and the pressure to keep submissions accurate, specific, and defensible is higher than ever.

So naturally, many payer teams are turning to auto-coding.

Auto-coding sounds like the answer. Faster chart processing. Less manual effort. More scale. The promise is compelling.

But it also creates a question that doesn’t get talked about enough:

If we scale faster, are we also scaling our RADV risk?

The honest answer is: it depends. Not on whether you automate, but on how the automation works.

“Auto-coding” isn’t one thing

One of the biggest mistakes payers make is treating auto-coding like a single category.

It isn’t.

There are very different approaches under the hood, and they behave very differently when you’re operating in a CMS-regulated environment.

Many modern tools use machine learning AI. They analyze patterns from large datasets and predict what diagnoses might be present in the record. In many cases, they can boost productivity. They can surface common conditions quickly. They can help teams move faster.

But machine learning AI is, by design, probabilistic. It’s making a statistical estimate. It’s predicting what might be in the chart based on what it has seen before.

That’s a problem in risk adjustment, because CMS doesn’t reward “likely.” CMS rewards what is explicitly documented and defensible.

When automation is driven by prediction, it can introduce two kinds of exposure at the same time.

First, false positives. A model suggests a code that isn’t clearly supported by documentation. Under time pressure, coders can be nudged toward accepting what the model presented, even when the medical record doesn’t explicitly confirm it.

Second, false negatives. Machine learning AI systems tend to perform best on diagnoses that appear frequently in the training data. Rare, nuanced, or highly specific diagnoses can be missed because the model simply hasn’t seen them enough to recognize them reliably. Unfortunately, those rarer diagnoses are often some of the most valuable ones to capture correctly in a risk adjustment program.

So, you end up in a painful place: automation that speeds up workflow while introducing compliance uncertainty and leaving reimbursement on the table.

The better question is “Does it confirm or does it predict?”

If you’re evaluating auto-coding, there’s one distinction that matters more than anything else:

Does the system confirm what is documented, or does it predict what might be true?

Deterministic, documentation-confirming, rules-based approaches like Precise Word Matching AI work differently than machine learning AI. Instead of statistical inference, they rely on explicit clinical language. Instead of “best guess,” they operate on confirmation. They match what is actually present in the record and tie it to the most specific code supported by documentation.

In practical terms, that means scaling doesn’t have to be a tradeoff.

Auto-coding can increase throughput and reduce labor burden without increasing RADV risk, but only when the logic behind it aligns with how CMS evaluates compliance: documentation support, specificity, and defensibility.

What to look for before you scale

Most automation conversations focus on accuracy percentages and throughput numbers. Those matter, but they don’t tell the whole story. What you want is performance that holds up under scrutiny, not just a speed boost.

When you’re evaluating an auto-coding solution, here are the questions that actually protect you:

Start with the engine: is it probabilistic or deterministic? If it’s predicting based on patterns, you’ll need more downstream validation to stay safe. If it’s confirming explicit documentation, the compliance posture is fundamentally stronger.

Then ask whether every code can be traced directly to exact clinical text. If your compliance team can’t quickly point to where and why a code was generated, that becomes a vulnerability during RADV.

Pay close attention to rare, complex and combination codes. Don’t just ask how it performs on common conditions. Ask what happens at the edges. High-RAF diagnoses that are less frequent and more specific are often the ones that determine financial outcomes and audit volatility.

Look carefully at the false positive and false negative profile. Overcoding increases audit exposure. Undercoding suppresses reimbursement. Both create operational challenges and executive stress.

Ask about model drift and retraining requirements. When CMS introduces new ICD-10 codes, will the system be able to accurately code them on Day One, or will the system take weeks or months to train on the new codes? And will the system be backward compatible, so retrospective reviews find the correct codes for that coding year? 

Be sure that you are not introducing instability into your risk adjustment workflow. Payers need predictability, not performance that changes quietly over time.

Finally, consider the human impact. Does scaling reduce validation burden, or does it shift work onto coders who now spend their time correcting the output of statistical modeling? If automation creates more rework, you haven’t solved the throughput problem. You’ve just moved it.

Scaling shouldn’t make you more nervous

A lot of industry advice about scaling risk adjustment sounds like this:

“Add AI.”
“Boost productivity.”
“Process more charts.”

That’s fine as far as it goes. But it often misses the real executive question.

The real question isn’t “How do we code more charts?”

It’s “How do we code more charts without increasing audit risk?”

That’s a workflow design question, not a staffing question. It’s about whether your automation approach reinforces compliance or creates new uncertainty that you can’t fully see until audit season.

The takeaway

If there’s one idea to leave with, it’s this:

You can scale risk adjustment throughput safely, but only if your auto-coding approach confirms documentation with deterministic precision rather than predicts it.

Scaling with the wrong automation multiplies risk.
Scaling with the right approach reduces it, while improving financial outcomes.

And for payer leaders who are responsible for both performance and compliance, that distinction is the difference between speeding up the process while sleeping better at night, or not.